Zydus Lifesciences Ltd. (ZYDUSLIFE): Zydus Lifesciences Share Price near 52-week high as stock trades at Rs 1,188

Zydus Lifesciences Share Price traded at Rs 1,188, up 1.58% from the previous close, and stayed near its 52-week high with a market capitalisation of Rs 1,15,810.19 crore.

Zydus Lifesciences Share Price is in focus today after Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,188, up Rs 18.50 or 1.58% from the previous close of Rs 1,169.50. The stock remained close to its one-year high and 52-week peak, while the company’s market capitalisation stood at Rs 1,15,810.19 crore. The latest Univest figures show an intraday range of Rs 1,162.65 to Rs 1,191, with the stock opening at Rs 1,169.95 and spending time near the upper end of that band. This Zydus Lifesciences Share Price move makes the stock news relevant for readers tracking Zydus Lifesciences Share Price Today, especially as the market weighs the price event alongside valuation and sector context rather than a company-specific trigger.

Zydus Lifesciences Share Price Today: Price Action Analysis

For investors scanning Zydus Lifesciences Stock News, the key point is straightforward: the price event is confirmed, but the available market data does not establish a company-specific catalyst. Zydus Lifesciences Share Price remains a stock to watch in the Indian Stock Market because the move keeps it close to the yearly high while leaving the broader fundamental picture in view. Univest tracks this Zydus Lifesciences Share Price update alongside sector benchmarks so readers can see whether the current pricing fits the underlying financial profile.

Metric	Value
Current Price	Rs 1,188
Previous Close	Rs 1,169.5
Today's Move	+Rs 18.5 (+1.58%)
Open	Rs 1,169.95
High	Rs 1,191
Low	Rs 1,162.65
Turnover	Rs 9.43 crore
Market Capitalisation	Rs 1,15,810.19 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) traded at Rs 1,188 versus the previous close of Rs 1,169.5, a rise of 1.58%. The stock opened at Rs 1,169.95, reached a high of Rs 1,191 and touched a low of Rs 1,162.65.

Zydus Lifesciences Share Price Today showed a firm intraday tone in the sense that the stock traded above the previous close and finished the observed period near the day’s high. The opening print was Rs 1,169.95, the low was Rs 1,162.65, and the high was Rs 1,191, which places the current trade of Rs 1,188 very close to the top of the range. Turnover stood at Rs 9.43 crore, which gives a factual read on traded value without adding any inference about participation. For readers searching Zydus Lifesciences Share Price Live or Zydus Lifesciences Share Price News, the event is best understood as a near 52-week high setup rather than a fresh record. Zydus Lifesciences Share News therefore centres on the price staying close to its yearly high and on whether the move remains aligned with the company’s fundamentals and sector valuation backdrop.

Zydus Lifesciences Ltd. (ZYDUSLIFE) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,15,810.19 crore
P/E Ratio	25.85x
P/B Ratio	4.33x
ROE	19.69%
ROCE	21.39%
EPS	Rs 45.24
Book Value Per Share	Rs 270.31
Dividend Yield	0.09%

Zydus Lifesciences Ltd. (ZYDUSLIFE) fundamental metrics show P/E 25.85x, P/B 4.33x, ROE 19.69%, ROCE 21.39%. These figures provide context only and are not a buy or sell signal.

Zydus Lifesciences Ltd. has a market capitalisation of Rs 115810.19 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.85x, P/B at 4.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 19.69% and ROCE of 21.39%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 45.24, book value per share of Rs 270.31, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.44x, median ROE of 11.69%, median ROCE of 13.32%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	25.85x
Benchmark Median P/E	28.44x
Benchmark Average P/E	42.34x
Benchmark P/E Range	0x to 762.66x
Company P/B Ratio	4.33x
Benchmark Median P/B	2.9x
Company ROE	19.69%
Benchmark Median ROE	11.69%
Company ROCE	21.39%
Benchmark Median ROCE	13.32%
Company Market Capitalisation	Rs 1,15,810.19 crore
Benchmark Median Market Cap	Rs 745.38 crore

Zydus Lifesciences Ltd. (ZYDUSLIFE) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 25.85x, which is below the benchmark median of 28.44x, a difference of -9.11%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROE of 19.69%, which is above the benchmark median of 11.69%, a difference of +68.43%. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a ROCE of 21.39%, which is above the benchmark median of 13.32%, a difference of +60.59%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Cipla Ltd.	CIPLA	1,11,565.25	33.08	3.17	11.83	16
Laurus Labs Ltd.	LAURUSLABS	1,08,338	100.55	19.5	18.31	18.2
Mankind Pharma Ltd.	MANKIND	1,02,410.4	49.79	6.04	12.69	13.24
Dr. Reddy's Laboratories Ltd.	DRREDDY	1,01,163.25	31.35	2.65	11.69	13.75
Aurobindo Pharma Ltd.	AUROPHARMA	97,641.63	26.73	2.55	9.93	12.76

Zydus Lifesciences Ltd. (ZYDUSLIFE) has a P/E ratio of 25.85x compared with the displayed peer median of 33.08x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 19.69% compares with a peer median of 11.83% across the companies shown in the table. ROCE stood at 21.39% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Zydus Lifesciences Ltd. (ZYDUSLIFE) has a market capitalisation of Rs 1,15,810.19 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

Why Investors Are Watching Zydus Lifesciences

• Zydus Lifesciences Share Price traded at Rs 1,188, above the previous close of Rs 1,169.50.
• The stock stayed near its 52-week high and one-year high during the latest market update.
• Market capitalisation stood at Rs 1,15,810.19 crore, keeping the company above the Rs 1 lakh crore mark.
• P/E at 25.85 is below the industry median of 28.44, while ROE at 19.69% and ROCE at 21.39% sit above the benchmark medians.
• Revenue for Jun 2026 was Rs 80,170 crore, higher than Rs 65,737 crore in Jun 2025.

About Zydus Lifesciences

Zydus Lifesciences Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The stock trades on NSE and BSE under the symbol ZYDUSLIFE. Zydus Lifesciences Share Price today reflects how the market is placing the company’s current valuation, financial returns and industry position into one visible price update. In this Zydus Lifesciences Stock News article, Univest keeps the company profile focused on the verified sector and industry classification rather than adding unsupported business detail.

Frequently Asked Questions

Why is Zydus Lifesciences Share Price in focus today?

Ans. Zydus Lifesciences Share Price is in focus because it traded at Rs 1,188, up 1.58% from the previous close, and stayed close to its 52-week high while the market cap remained above Rs 1 lakh crore.

What is Zydus Lifesciences Share Price today?

Ans. Zydus Lifesciences Share Price today stood at Rs 1,188 in the latest market update. The previous close was Rs 1,169.50, and the intraday range extended from Rs 1,162.65 to Rs 1,191.

Is Zydus Lifesciences near its 52-week high?

Ans. Yes. Zydus Lifesciences Share Price remained near its 52-week high and one-year high, with the latest trade at Rs 1,188 and the day’s high at Rs 1,191. The stock moved 1.58% so far today.

What does Zydus Lifesciences Share Price say about valuation?

Ans. Zydus Lifesciences Share Price is backed by a P/E of 25.85 and a P/B of 4.33. In the same industry set, the P/E is below the median while the P/B is above the median.

How do Zydus Lifesciences fundamentals look?

Ans. Zydus Lifesciences Fundamental Analysis shows ROE of 19.69%, ROCE of 21.39%, EPS of Rs 45.24 and book value of Rs 270.31. Dividend yield stands at 0.09%, adding context to the share price.

How does Zydus Lifesciences compare with pharma peers?

Ans. Zydus Lifesciences Share Price sits alongside peers such as Cipla, Dr. Reddy’s, Aurobindo Pharma, Mankind Pharma and Laurus Labs. Its return ratios are stronger than several listed peers in the comparison set.

What sector does Zydus Lifesciences belong to?

Ans. Zydus Lifesciences belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector context helps readers compare Zydus Lifesciences Share Price with the broader pharma basket on Univest.

Where can I track Zydus Lifesciences Share Price live?

Ans. You can track Zydus Lifesciences Share Price on Univest for live price updates, valuation ratios, market capitalisation, sector context and 52-week levels. The platform keeps the stock news and share price update in one place.

Track Zydus Lifesciences Share Price on Univest

Use Zydus Lifesciences Ltd. (ZYDUSLIFE) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Zydus Lifesciences Share Price on Univest for live price updates, market cap, valuation ratios, company financials, sector context and 52-week levels. Univest also helps readers follow Zydus Lifesciences Stock Analysis, Zydus Lifesciences Latest News and Zydus Lifesciences Share Price Update in one place.